 Bromocriptine
"Bromocriptine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.
| Descriptor ID |
D001971
|
| MeSH Number(s) |
D03.132.327.412.100 D03.549.439.131 D03.549.562.100
|
| Concept/Terms |
Bromocriptine- Bromocriptine
- 2-Bromo-alpha-ergokryptine
- 2 Bromo alpha ergokryptine
- Bromocryptin
- 2-Bromoergokryptine
- 2 Bromoergokryptine
- Bromocriptin
- 2-Bromoergocryptine
- 2 Bromoergocryptine
- 2-Bromo-alpha-ergocryptine
- 2 Bromo alpha ergocryptine
2-Bromoergocryptine Mesylate- 2-Bromoergocryptine Mesylate
- 2 Bromoergocryptine Mesylate
- Mesylate, 2-Bromoergocryptine
- Bromocriptine Mesylate
- Mesylate, Bromocriptine
- 2-Bromoergocryptine Methanesulfonate
- 2 Bromoergocryptine Methanesulfonate
- Methanesulfonate, 2-Bromoergocryptine
|
Below are MeSH descriptors whose meaning is more general than "Bromocriptine".
Below are MeSH descriptors whose meaning is more specific than "Bromocriptine".
This graph shows the total number of publications written about "Bromocriptine" by people in this website by year, and whether "Bromocriptine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 1 | 0 | 1 | | 1983 | 1 | 0 | 1 | | 1988 | 0 | 1 | 1 | | 1995 | 0 | 1 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2000 | 0 | 1 | 1 | | 2002 | 0 | 2 | 2 | | 2004 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bromocriptine" by people in Profiles.
-
Narkar V, Kunduzova O, Hussain T, Cambon C, Parini A, Lokhandwala M. Dopamine D2-like receptor agonist bromocriptine protects against ischemia/reperfusion injury in rat kidney. Kidney Int. 2004 Aug; 66(2):633-40.
-
Narkar VA, Hussain T, Lokhandwala MF. Activation of D2-like receptors causes recruitment of tyrosine-phosphorylated NKA alpha 1-subunits in kidney. Am J Physiol Renal Physiol. 2002 Dec; 283(6):F1290-5.
-
Narkar V, Hussain T, Lokhandwala M. Role of tyrosine kinase and p44/42 MAPK in D(2)-like receptor-mediated stimulation of Na(+), K(+)-ATPase in kidney. Am J Physiol Renal Physiol. 2002 Apr; 282(4):F697-702.
-
Carlezon WA, Kosten TA, Nestler EJ. Behavioral interactions caused by combined administration of morphine and MK-801 in rats. Psychopharmacology (Berl). 2000 Aug; 151(2-3):261-72.
-
Hussain T, Abdul-Wahab R, Kotak DK, Lokhandwala MF. Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules. Hypertension. 1998 Dec; 32(6):1054-9.
-
Hussain T, Abdul-Wahab R, Lokhandwala MF. Bromocriptine stimulates Na+, K(+)-ATPase in renal proximal tubules via the cAMP pathway. Eur J Pharmacol. 1997 Feb 26; 321(2):259-63.
-
Kansra V, Chen C, Lokhandwala MF. Dopamine causes stimulation of protein kinase C in rat renal proximal tubules by activating dopamine D1 receptors. Eur J Pharmacol. 1995 Apr 28; 289(2):391-4.
-
Morgan C, Kosten T, Gawin F, Kleber H. A pilot trial of amantadine for ambulatory withdrawal for cocaine dependence. NIDA Res Monogr. 1988; 81:81-5.
-
Hamed AT, Ginos JZ, Ekas RD, Jandhyala BS, Lokhandwala MF. Renal hemodynamics in hemorrhagic hypotension: studies on the effects of pre- and postjunctional dopamine receptor agonists. J Cardiovasc Pharmacol. 1983 Mar-Apr; 5(2):207-12.
-
Hamed AT, Lokhandwala MF, Jandhyala BS. Effect of bromocriptine on cardiac function and coronary blood flow. J Cardiovasc Pharmacol. 1981 May-Jun; 3(3):636-46.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|